| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
RELA |
RELA, NFKB3: Transcription factor p65 |
18.500 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
18.430 |
Evidence |
O
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
LYN |
LYN: Tyrosine-protein kinase Lyn |
18.430 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
IL3RA |
IL3RA, IL3R: Interleukin-3 receptor alpha chain precursor |
18.230 |
Evidence |
O
|
| RB1 |
RB1: Retinoblastoma-associated protein |
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
18.190 |
Evidence |
O
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
18.180 |
Evidence |
O
|
| TNFSF9 |
TNFSF9: Tumor necrosis factor ligand superfamily member 9 |
TNFRSF9 |
TNFRSF9, CD137, ILA: Tumor necrosis factor receptor superfamily member 9 precurs |
17.980 |
Evidence |
O
|
| TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
ID4 |
ID4: DNA-binding protein inhibitor ID-4 |
17.980 |
Evidence |
|
| CHRNB4 |
CHRNB4: Neuronal acetylcholine receptor subunit beta-4 precursor |
CHRNA3 |
IPI00297165 |
17.980 |
Evidence |
|
| DFFB |
DFFB, CAD, DFF2, DFF40: DNA fragmentation factor subunit beta |
CIDEB |
CIDEB: Cell death activator CIDE-B |
17.980 |
Evidence |
|
| ITPR3 |
ITPR3: Inositol 1,4,5-trisphosphate receptor type 3 |
TRPC6 |
TRPC6, TRP6: Short transient receptor potential channel 6 |
17.980 |
Evidence |
|
| TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
17.980 |
Evidence |
|
| KCNJ5 |
KCNJ5, GIRK4: G protein-activated inward rectifier potassium channel 4 |
KCNJ3 |
KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 |
17.980 |
Evidence |
O
|
| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
NUP153 |
IPI00514528 |
17.910 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
17.910 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
EP300 |
IPI00478752 |
17.870 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
17.870 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
17.730 |
Evidence |
|
| RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
17.690 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
HNRPD |
HNRPD, AUF1: Heterogeneous nuclear ribonucleoprotein D0 |
17.690 |
Evidence |
|
| CREB1 |
CREB1: cAMP response element-binding protein |
CREBBP |
CREBBP, CBP: CREB-binding protein |
17.690 |
Evidence |
|
| SNRPD3 |
SNRPD3: Small nuclear ribonucleoprotein Sm D3 |
SMN2 |
SMN1, SMN, SMN2, SMNC, SMNT: Survival motor neuron protein |
17.690 |
Evidence |
|
| PARD3 |
IPI00154915 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
17.690 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
17.690 |
Evidence |
O
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
17.690 |
Evidence |
O
|
